Tanshinone IIA combined with cisplatin synergistically inhibits non‐small‐cell lung cancer in vitro and in vivo via down‐regulating the phosphatidylinositol 3‐kinase/Akt signalling pathway
Xiaozhong Liao(Southern Medical University), Lizhu Lin(Guangzhou University of Chinese Medicine)
Cited by 64
Related Papers
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
|The Lancet Respiratory Medicine|2020|504
Network pharmacology based research into the effect and mechanism of Yinchenhao Decoction against Cholangiocarcinoma
|Chinese Medicine|2021|95